ad info

CNNin
 MAIN PAGE
 WORLD
 ASIANOW
 U.S.
 LOCAL
 POLITICS
 WEATHER
 BUSINESS
 SPORTS
 TECHNOLOGY
 NATURE
 ENTERTAINMENT
 BOOKS
 TRAVEL
 FOOD
 HEALTH
 AIDS
 Alternative
 Cancer
 Diet & Fitness
 Heart
 Men
 Seniors
 Women
 STYLE
 IN-DEPTH

 Headline News brief
 daily almanac
 CNN networks
 CNN programs
 on-air transcripts
 news quiz

  CNN WEB SITES:
CNN Websites
 TIME INC. SITES:
 MORE SERVICES:
 video on demand
 video archive
 audio on demand
 news email services
 free email accounts
 desktop headlines
 pointcast
 pagenet

 DISCUSSION:
 message boards
 chat
 feedback

 SITE GUIDES:
 help
 contents
 search

 FASTER ACCESS:
 europe
 japan

 WEB SERVICES:
Health

Consumer group objects to 'off-label' drug promotion

June 25, 1998
Web posted at: 11:39 p.m. EDT (0339 GMT)
Graphic

WASHINGTON (CNN) -- A consumer watchdog group says a plan to allow drugs to be promoted as treatment for diseases other than the ones for which they are approved is bad news for patients.

Doctors often discover that a drug approved to treat one ailment can effectively treat another. For example, the celebrated impotency drug Viagra was originally approved to treat chest pain caused by heart disease.

It is already legal for doctors to prescribe drugs for unapproved purposes, called "off-label" uses. However, until now, drug companies could not officially inform physicians, pharmacists or insurers of other potential uses.

A new law changes that, and the U.S. Food and Drug Administration is proposing new rules that will implement the law.

The consumer watchdog group Public Citizen is critical of the plan.

"In a sense, huge numbers of people are going to be made guinea pigs for unapproved uses of drugs," said Dr. Sidney Wolfe of Public Citizen.(icon 179K/13 sec. AIFF or WAV sound)

Viagra
Viagra was originally used to treat chest pain  

The FDA's new rules would allow the companies to promote off-label uses while placing restrictions on the kind of information distributed in the process. For example, the regulations would prevent companies from distributing false or misleading information.

Drug companies say the requirements are strict enough, and that the new law makes sense.

"There are many patients who use drugs off-label that if they had to wait for it to come on-label would be tremendously disadvantaged," said Dr. John Siegfried, senior clinical advisor for Pharmaceutical Research and Manufacturers of America.(icon 204K/16 sec. AIFF or WAV sound)

Reporter Louise Schiavone contributed to this report.

Related stories:
Latest Headlines

Today on CNN

Related sites:

Note: Pages will open in a new browser window

External sites are not
endorsed by CNN Interactive.

SEARCH CNN.com
Enter keyword(s)   go    help

  
 

Back to the top
© 2000 Cable News Network. All Rights Reserved.
Terms under which this service is provided to you.
Read our privacy guidelines.